I agree that this site is using cookies. You can find further informations here.
X
Tortorici, Michael A.
86  results:
Search for persons X
?
1

Centyrin-targeted glycogen synthase-1 siRNA conjugates: A n..:

Tortorici, Michael A. ; Nadler, Steven ; Archer, Chase...
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107337 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Effect of CSL112 (apolipoprotein A‐I [human]) on cholestero..:

Zheng, Bo ; Goto, Shinya ; Clementi, Regina...
Clinical and Translational Science.  15 (2022)  10 - p. 2331-2341 , 2022
Link: https://doi.org/10.1111/..
 
?
3

Pharmacometric analysis linking immunoglobulin exposure to ..:

Tortorici, Michael A. ; Yuraszeck, Theresa ; Cornblath, David...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  8 - p. 839-850 , 2021
Link: https://doi.org/10.1002/..
 
?
4

Current and Next Steps Toward Prediction of Human Dose for ..:

Aksenov, Sergey ; Roberts, John C. ; Mugundu, Ganesh...
Clinical Pharmacology & Therapeutics.  110 (2021)  5 - p. 1176-1179 , 2021
Link: https://doi.org/10.1002/..
 
?
5

Pharmacokinetic/pharmacodynamic modeling for dose selection..:

Pawaskar, Dipti ; Chen, Xi ; Glassman, Fiona...
Clinical and Translational Science.  15 (2021)  3 - p. 709-720 , 2021
Link: https://doi.org/10.1111/..
 
?
6

Population pharmacokinetic analysis of weekly and biweekly ..:

Zhang, Ying ; Baheti, Gautam ; Chapdelaine, Hugo...
International Immunopharmacology.  81 (2020)  - p. 106005 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Pharmacometric Analysis of IgPro10 in Japanese and Non-Japa..:

Luo, Dandan ; Baheti, Gautam ; Tortorici, Michael A...
Clinical Therapeutics.  42 (2020)  1 - p. 196-209.e5 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Pharmacometric modeling to explore 4F-PCC dosing strategies..:

Sarode, Ravi ; Fukutake, Katsuyuki ; Yasaka, Masahiro...
Blood Advances.  4 (2020)  17 - p. 4208-4216 , 2020
Link: https://doi.org/10.1182/..
 
?
9

Pharmacometric analyses to characterize the effect of CSL11..:

Zheng, Bo ; Duffy, Danielle ; Tricoci, Pierluigi...
British Journal of Clinical Pharmacology.  87 (2020)  6 - p. 2558-2571 , 2020
Link: https://doi.org/10.1111/..
 
?
10

Privigen® has similar pharmacokinetic properties in primary..:

Tortorici, Michael A. ; Lawo, John-Philip ; Weide, Rudolf...
International Immunopharmacology.  66 (2019)  - p. 119-126 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Pharmacokinetic properties of Privigen® in Japanese patient..:

Morio, Tomohiro ; Baheti, Gautam ; Tortorici, Michael A...
Immunological Medicine.  42 (2019)  4 - p. 162-168 , 2019
Link: https://doi.org/10.1080/..
 
?
12

Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 ..:

Rojavin, Mikhail A. ; Chapdelaine, Hugo ; Tortorici, Michael A....
Clinical Pharmacology in Drug Development.  9 (2019)  6 - p. 664-670 , 2019
Link: https://doi.org/10.1002/..
 
?
13

Pharmacokinetics and Safety of CSL112 (Apolipoprotein A‐I [..:

Tortorici, Michael A. ; Duffy, Danielle ; Evans, Rebecca...
Clinical Pharmacology in Drug Development.  8 (2018)  5 - p. 628-636 , 2018
Link: https://doi.org/10.1002/..
 
?
14

Moderate Renal Impairment Does Not Impact the Ability of CS..:

Gille, Andreas ; Duffy, Danielle ; Tortorici, Michael A....
The Journal of Clinical Pharmacology.  59 (2018)  3 - p. 427-436 , 2018
Link: https://doi.org/10.1002/..
 
?
15

Pharmacokinetics of Hizentra at Weekly vs. Biweekly Dosing ..:

Rojavin, Mikhail ; Chapdelaine, Hugo ; Baheti, Gautam...
Journal of Allergy and Clinical Immunology.  141 (2018)  2 - p. AB20 , 2018
Link: https://doi.org/10.1016/..
 
1-15